Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 48:206-214, doi:10.1016/j.jacc.2006.04.044 (Published online 9 May 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Appendix
Right arrow All Versions of this Article:
j.jacc.2006.04.044v1
48/1/206    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mangano, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mangano, D. T.

EXPEDITED REVIEW

Post-Reperfusion Myocardial Infarction

Long-Term Survival Improvement Using Adenosine Regulation With Acadesine

Dennis T. Mangano, PhD, MD*, Yinghui Miao, MD, MS, Iulia C. Tudor, PhD, Cynthia Dietzel, MDfor the for the Investigators of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group the Ischemia Research and Education Foundation (IREF)

Ischemia Research and Education Foundation (IREF), San Bruno, California

Manuscript received February 7, 2006; revised manuscript received March 30, 2006, accepted April 4, 2006.

* Reprint requests and correspondence: Dr. Dennis T. Mangano, Editorial Office, Ischemia Research and Education Foundation, 1111 Bayhill Drive, Suite 480, San Bruno, California 94066 (Email: dtb{at}iref.org).

OBJECTIVES: The purpose of this study was to assess the safety and efficacy of the adenosine regulating agent (ARA) acadesine for reducing long-term mortality among patients with post-reperfusion myocardial infarction (MI).

BACKGROUND: No prospectively applied therapy exists that improves long-term survival after MI associated with coronary artery bypass graft (CABG) surgery—a robust model of ischemia/reperfusion injury. Pretreatment with the purine nucleoside autocoid adenosine mitigates the extent of post-ischemic reperfusion injury in animal models. Therefore, we questioned whether use of the ARA acadesine—by increasing interstitial adenosine concentrations in ischemic tissue—would improve long-term survival after post-reperfusion MI.

METHODS: At 54 institutions, 2,698 patients undergoing CABG surgery were randomized to receive placebo (n = 1,346) or acadesine (n = 1,352) by intravenous infusion (0.1 mg/kg/min; 7 h) and in cardioplegia solution (placebo or acadesine; 5 µg/ml). Myocardial infarction was prospectively defined as: 1) new Q-wave and MB isoform of creatine kinase (CK-MB) elevation (daily electrocardiography; 16 serial CK-MB measurements); or 2) autopsy evidence. Vital status was assessed over 2 years, and outcomes were adjudicated centrally.

RESULTS: Perioperative MI occurred in 100 patients (3.7%), conferring a 4.2-fold increase in 2-year mortality (p < 0.001) compared with those not suffering MI. Acadesine treatment, however, reduced that mortality by 4.3-fold, from 27.8% (15 of 54; placebo) to 6.5% (3 of 46; acadesine) (p = 0.006), with the principal benefit occurring over the first 30 days after MI. The acadesine benefit was similar among diverse subsets, and multivariable analysis confirmed these findings.

CONCLUSIONS: Acadesine is the first therapy proven to be effective for reducing the severity of acute post-reperfusion MI, substantially reducing the risk of dying over the 2 years after infarction.

Abbreviations and Acronyms
  ARA = adenosine regulating agent
  CABG = coronary artery bypass graft
  CK-MB = MB isoform of creatine kinase
  MI = myocardial infarction
  PCI = percutaneous coronary intervention




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 4 - 34.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
Special Article: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Anesth. Analg., January 1, 2012; 114(1): 11 - 45.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., December 6, 2011; 58(24): 2584 - 2614.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., December 6, 2011; 58(24): e123 - e210.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation, December 6, 2011; 124(23): e652 - e735.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation, December 6, 2011; 124(23): 2610 - 2642.
[Full Text] [PDF]


Home page
J Clin PharmacolHome page
M. Bosselaar, P. Smits, L. J. C. van Loon, and C. J. Tack
Intravenous AICAR During Hyperinsulinemia Induces Systemic Hemodynamic Changes but Has No Local Metabolic Effect
J. Clin. Pharmacol., October 1, 2011; 51(10): 1449 - 1458.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
R. M. Mentzer Jr
Myocardial Protection in Heart Surgery
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2011; 16(3-4): 290 - 297.
[Abstract] [PDF]


Home page
IOVSHome page
J. Suzuki, A. Manola, Y. Murakami, Y. Morizane, K. Takeuchi, M. Kayama, J. W. Miller, L. Sobrin, and D. G. Vavvas
Inhibitory Effect of Aminoimidazole Carboxamide Ribonucleotide (AICAR) on Endotoxin-Induced Uveitis in Rats
Invest. Ophthalmol. Vis. Sci., August 22, 2011; 52(9): 6565 - 6571.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
I. Koniari, B. Koletti, and E. Apostolakis
Perioperative myocardial infarction following coronary artery bypass grafting
Interact CardioVasc Thorac Surg, April 1, 2011; 12(4): 599 - 599.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. W. Hammon
Why change?
J. Thorac. Cardiovasc. Surg., December 1, 2010; 140(6): 1218 - 1219.
[Full Text] [PDF]


Home page
HeartHome page
R. K. Kharbanda
Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury
Heart, August 1, 2010; 96(15): 1179 - 1186.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. M. Myerburg, J. D. King Jr., N. M. Oyster, A. C. Fitch, A. Magill, C. J. Baty, S. C. Watkins, J. K. Kolls, J. M. Pilewski, and K. R. Hallows
AMPK Agonists Ameliorate Sodium and Fluid Transport and Inflammation in Cystic Fibrosis Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol., June 1, 2010; 42(6): 676 - 684.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Zhang, J. Wang, H. Wang, R. Tang, J. D. Belcher, B. Viollet, J. G. Geng, C. Zhang, C. Wu, A. Slungaard, et al.
Acadesine Inhibits Tissue Factor Induction and Thrombus Formation by Activating the Phosphoinositide 3-Kinase/Akt Signaling Pathway
Arterioscler Thromb Vasc Biol, May 1, 2010; 30(5): 1000 - 1006.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Pang, V. Rajapurohitam, M. A. Cook, and M. Karmazyn
Differential AMPK phosphorylation sites associated with phenylephrine vs. antihypertrophic effects of adenosine agonists in neonatal rat ventricular myocytes
Am J Physiol Heart Circ Physiol, May 1, 2010; 298(5): H1382 - H1390.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. L. Hale and R. A. Kloner
Cardioprotection With Adenosine-Regulating Agent, GP531: Effects on No-Reflow, Infarct Size, and Blood Flow Following Ischemia/ Reperfusion in the Rabbit
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2010; 15(1): 60 - 67.
[Abstract] [PDF]


Home page
FASEB J.Home page
J. M. W. Quinn, S. Tam, N. A. Sims, H. Saleh, N. E. McGregor, I. J. Poulton, J. W. Scott, M. T. Gillespie, B. E. Kemp, and B. J. W. van Denderen
Germline deletion of AMP-activated protein kinase {beta} subunits reduces bone mass without altering osteoclast differentiation or function
FASEB J, January 1, 2010; 24(1): 275 - 285.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Bosselaar, H. Boon, L. J. C. van Loon, P. H. H. van den Broek, P. Smits, and C. J. Tack
Intra-arterial AICA-riboside administration induces NO-dependent vasodilation in vivo in human skeletal muscle
Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E759 - E766.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
V. Venugopal, A. Ludman, D. M. Yellon, and D. J. Hausenloy
'Conditioning' the heart during surgery
Eur J Cardiothorac Surg, June 1, 2009; 35(6): 977 - 987.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. A. Babraj, K. Mustard, C. Sutherland, M. C. Towler, S. Chen, K. Smith, K. Green, G. Leese, D. G. Hardie, M. J. Rennie, et al.
Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic status
Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1042 - E1048.
[Abstract] [Full Text] [PDF]


Home page
OCL CardioprotectionHome page
J. Pepper
Chapter 7 Cardioprotection During Cardiac Surgery
Cardiac Protection, January 1, 2009; 1(1): med-9780199544769-chapter - med-9780199544769-chapter.
[Abstract] [Full Text]


Home page
JAMAHome page
MEND-CABG II Investigators*
Efficacy and Safety of Pyridoxal 5'-Phosphate (MC-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery: The MEND-CABG II Randomized Clinical Trial
JAMA, April 16, 2008; 299(15): 1777 - 1787.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. J. Cuthbertson, J. A. Babraj, K. J.W. Mustard, M. C. Towler, K. A. Green, H. Wackerhage, G. P. Leese, K. Baar, M. Thomason-Hughes, C. Sutherland, et al.
5-Aminoimidazole-4-Carboxamide 1-{beta}-D-Ribofuranoside Acutely Stimulates Skeletal Muscle 2-Deoxyglucose Uptake in Healthy Men
Diabetes, August 1, 2007; 56(8): 2078 - 2084.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Maurer
Adenosine as an adjunct to reperfusion in myocardial infarction
Eur. Heart J., October 2, 2006; 27(20): 2376 - 2377.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. A. Kloner
Moving Preconditioning From Bench to Bedside
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 215 - 216.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement